Projects funded by the NCN
Role of Prolactin-Induced Protein (PIP) in breast cancer progression using an adjuvant therapy.
2016/23/B/NZ5/02647
Keywords:
PIP breast cancer apoptosis resistance.
Descriptors:
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski
woj. dolnośląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 12 - announced on 2016-09-15
Amount awarded: 1 885 870 PLN
Project start date (Y-m-d): 2017-08-11
Project end date (Y-m-d): 2021-08-10
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.